Table 2. Effect of CLN and NCLN on body weight in STZ-treated Diabetic Rats .
| Body weight (gr) | Repeated Measured Anova P-vlues | |||||||||
| Groups (n=6) | Treatment | Day 0 | Day 7 | Day 14 | Day 21 | Day 28 | Diabetes | Treatment | Interaction | Time |
| Non-diabetics | Control | 316.2±10.56 | 315.2±89.00 | 316.2±11.17 | 308.3±14.12 | 330.2±93.92 | <0.001 | <0.001 | <0.001 | <0.001 |
| CLN | 324.3±12.42 | 322.5±12.75 | 337.8±11.58 | 347.6±11.48 | 349.8±10.86 | |||||
| NCLN | 332.6±12.29 | 308.5±11.31 | 339.8±15.07 | 335.8±14.17 | 340.0±14.50 | |||||
| Diabetics | Control | 302.6±10.05* | 306.3±15.97 | 247.0±80.82 | 239.0±40.41* | 238.5±95.26 | ||||
| CLN | 323.3±11.72 | 299.8±12.31* | 280.1±14.70* | 260.0±14.88* | 270.0±94.81 | |||||
| NCLN | 312.1±13.18 | 325.0±76.68 | 268.3±13.15* | 265.0±13.99* | 270.8±14.88* | |||||
Data are expressed in terms of means ±SEM.; CLN= Clinoptilolite; NCLN= Nano-sized clinoptilolite, *Sidak tests p<0.05 compared to group 2 and time 28